Alterity Therapeutics Limited (ASX:ATH)
0.0100
0.00 (0.00%)
Apr 29, 2026, 4:10 PM AEST
Alterity Therapeutics Employees
Alterity Therapeutics had 9 employees as of June 30, 2025. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
737.38K AUD
Profits / Employee
-1.62M AUD
Market Cap
108.75M
Employees Chart
Alterity Therapeutics News
- 1 day ago - Regulatory Update on Alterity Therapeutics (ATHE) and ATH434 Development - GuruFocus
- 1 day ago - Alterity Therapeutics Gets Positive FDA Feedback On ATH434 Phase 3 Study - Nasdaq
- 1 day ago - Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy - GlobeNewsWire
- 6 days ago - Alterity Therapeutics (ATHE) Shows Promising Results in Phase 2 Trial for MSA - GuruFocus
- 6 days ago - Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology - GlobeNewsWire
- 11 days ago - Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors - GlobeNewsWire
- 4 weeks ago - Alterity Therapeutics (ATHE) Prepares for Phase 3 Trial After FDA Feedback - GuruFocus
- 4 weeks ago - Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program - GlobeNewsWire